Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$107.32 - $113.5 $5,687 - $6,015
-53 Reduced 2.16%
2,399 $262,000
Q4 2022

Feb 13, 2023

BUY
$62.39 - $113.8 $152,980 - $279,037
2,452 New
2,452 $279,000
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $182,143 - $266,929
-2,294 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$86.42 - $109.81 $198,247 - $251,904
2,294 New
2,294 $241,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.